Raily Aesthetic Medicine International Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
0.00
-70.00
-36.00
-25.00
-27.00
12.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
9.00
-9.00
1.00
-9.00
3.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
38.00
6.00
9.00
-2.00
-3.00
15.00
Cash Flow from Investing Activities
1.00
-12.00
-29.00
0.00
-95.00
-14.00
Cash Flow from Financing Activities
-8.00
20.00
-11.00
-29.00
10.00
104.00
Net Cash Inflow / Outflow
31.00
14.00
-30.00
-28.00
-90.00
105.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
3.00
-2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Raily Aesthetic Medicine International Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
0.668066396365137
-17.5031226800925
17.00
103.82%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
9.76938652346941
13.9133503230006
-4.00
-29.78%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
38.626384371657
19.4314052332373
19.00
98.78%
Cash Flow from Investing Activities
1.50965653204589
-13.7105444526754
14.00
111.01%
Cash Flow from Financing Activities
-8.74668098487798
8.85621784532096
-16.00
-198.76%
Net Cash Inflow / Outflow
31.3676694514105
12.7442341293616
19.00
146.13%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.0216904674144525
-1.83284449652124
1.00
98.82%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 516.68% vs -32.66% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
38.63
6.26
516.68%






